19 results
8-K
EX-99.1
GUTS
Fractyl Health Inc.
24 Jun 24
Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates
6:04am
treatment population for any of our product candidates or products, and our strategic and product development objectives and goals, including with respect … or commercialization of any of Company’s product candidates or products and our strategic and product development objectives and goals, and the other factors
10-Q
2024 Q1
EX-10.7
GUTS
Fractyl Health Inc.
13 May 24
Quarterly report
4:06pm
”). The Annual Bonus payable under the incentive program shall be based on the achievement of performance goals to be determined by the Board
10-Q
2024 Q1
GUTS
Fractyl Health Inc.
13 May 24
Quarterly report
4:06pm
other current or future product candidates and, accordingly, may not achieve our research, development and commercialization goals.
Risks Related … of the Company’s Board of Directors, based on achievement of performance goals and contingent upon Dr. Kieffer’s continued services to the Company. Dr. Kieffer
8-K
EX-99.1
GUTS
Fractyl Health Inc.
13 May 24
Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
4:01pm
of time, and our strategic and product development objectives and goals, including with respect to enabling long-term control over obesity and type 2 … or products and our strategic and product development objectives and goals, and the other factors discussed under the caption “Risk Factors” in our
10-K
2023 FY
GUTS
Fractyl Health Inc.
1 Apr 24
Annual report
7:15am
should be applied to T2D as is now already evident in T1D therapeutic development with goals of 1) diabetes prevention, defined as whether the treatment … believe goals for anti-obesity medications should be 1) weight maintenance, defined as the prevention of weight regain over the course of at least one year
10-K
EX-10.14
kx67utdjhm1 mo36
1 Apr 24
Annual report
7:15am
8-K
EX-99.1
denml 91ls
1 Apr 24
Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
7:10am
8-K
EX-99.1
ne9i1l
1 Apr 24
Regulation FD Disclosure
6:09am
424B4
rpws zuunmqmhn7pg7
2 Feb 24
Prospectus supplement with pricing info
4:18pm
S-1/A
EX-10.8
0bdyn33
29 Jan 24
IPO registration (amended)
6:09am
S-1/A
EX-10.7
de89etrgyb6qa m5n8ch
29 Jan 24
IPO registration (amended)
6:09am
S-1/A
EX-10.15
hxlj7 um1
29 Jan 24
IPO registration (amended)
6:09am
S-1/A
EX-10.5
3d1 28uy5mac
29 Jan 24
IPO registration (amended)
6:09am
S-1/A
exq4uoprwz
29 Jan 24
IPO registration (amended)
6:09am
S-1/A
EX-10.9
nwa9mi
29 Jan 24
IPO registration (amended)
6:09am
S-1/A
EX-10.6
oixd i6lt8r
29 Jan 24
IPO registration (amended)
6:09am
S-1
c97a1qr4b1ww
14 Dec 23
IPO registration
3:39pm
DRS/A
dqnghj2wt
21 Sep 23
Draft registration statement (amended)
12:00am
DRS/A
f4eatk p1m
22 Aug 23
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next